摘要
目的探讨糖皮质激素用于治疗儿童支原体肺炎的疗效。方法随机抽取2012年4月~2014年11月诊治的120例支原体肺炎患儿,分为研究组和对照组,每组44例,对照组患儿使用阿奇霉素进行治疗,研究组在对照组的基础上增加甲泼尼龙琥珀酸钠进行治疗,分析两组的治疗效果。结果研究组的治疗总有效率为显著高于对照组,差异有统计学意义（P〈0.05）,研究组的住院时间、胸片明显改善例数、咳嗽缓解时间、退热时间等显著低于对照组,差异有统计学的意义（P〈0.05）,两组的不良反应发生率无明显改变,差异无统计学意义（P〉0.05）。结论糖皮质激素用于治疗儿童支原体肺炎具有效果好,安全性高、稳定性强等优点,值得在临床治疗上推广使用。
Objective To analyze the therapeutic effect of glucocorticoid in the treatment of Mycoplasma pneumonia in children. Methods 120 cases of children with Mycoplasma pneumonia treated from April 2012 to 2014 November,was randomly selected,and were divided into study group and control group,44 cases in each group.Contrast group was treated with azithromycin treatment,the study group was increased with the treatment of methylprednisolone sodium succinate,and the therapeutic effect of the two groups were analyzed. Results The total effective rate in the study group was significantly higher than that of the contrast group,the difference between the two groups was statistically significant（P 〈0.05）.Research group of the hospitalization time,chest X-ray is obviously improved,the number of patients with cough relief time,cooling time was significantly lower than that of the contrast group,between the difference has statistical significance（P〈0.05）.There was no significant difference in the incidence of adverse reactions between the two groups（P〉0.05）. Conclusion Glucocorticoid is effective and safe in treatment of children with Mycoplasma pneumonia,which is worthy of promotion in clinical treatment.
出处
《中国当代医药》
2016年第1期169-171,共3页
China Modern Medicine
关键词
糖皮质激素
儿童
支原体肺炎
疗效分析
Glucocorticoid
Children
Mycoplasma pneumonia
Curative effect analysis
